Mécanismes moléculaires de la sclérose latérale amyotrophique : apports récents de l’analyse de modèles animaux
- 31 January 2004
- journal article
- abstracts
- Published by Elsevier in Revue Neurologique
- Vol. 160 (1) , 35-43
- https://doi.org/10.1016/s0035-3787(04)70845-0
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Transgenic ALS Mice Show Increased Vulnerability to the Mitochondrial Toxins MPTP and 3-Nitropropionic AcidExperimental Neurology, 2001
- Blood oxidative stress in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 2000
- Beneficial Effects of Lysine Acetylsalicylate, a Soluble Salt of Aspirin, on Motor Performance in a Transgenic Model of Amyotrophic Lateral SclerosisExperimental Neurology, 1999
- Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1Science, 1998
- Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosisAnnals of Neurology, 1997
- Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutantProceedings of the National Academy of Sciences, 1997
- ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing InclusionsNeuron, 1997
- Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosisNeuroscience Letters, 1995
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndromeBrain Research, 1991